IntraMedical Imaging LLC
IntraMedical Imaging LLC (IMI) is a privately-held diagnostic company, engaged in the marketing of instruments for surgery to detect nodes in tumor and lymph. IMI technology is based on the injection of special isotope labeled pharmaceuticals that emit gamma or beta rays. It markets a family of surgical probes including Gamma Probes for sentinel lymph node mapping and PET Probes for tumor detection. The product portfolio of the company includes node seeker control unit, gamma probes, beta or positron probe. Additionally, the company also provides clinical applications. It is a ISO 13485 certified company. The company markets its products in domestic market through its own sales force/distributors in the US and in international markets through distributors and independent sales representatives. IMI is headquartered in California, the US.